Saadat Hassan: Who Protects the Embryo after Vitrification?

The Cryostorage Quality System Behind Long-Term IVF Safety

“Why is cryostorage a continuation of IVF laboratory quality?

An IVF laboratory invests substantial effort in creating, selecting, and preserving reproductive cells and embryos. Oocytes are retrieved, sperm are prepared, fertilization is performed, embryos are cultured, and selected specimens may undergo vitrification for future use. Yet once vitrification is completed, the laboratory’s responsibility does not simply end.

It enters a different phase.

Cryostorage is the system through which the biological material produced by the laboratory is protected over time. A cryogenic tank may appear to be a passive storage device, but reliable cryostorage depends on much more than maintaining a low temperature. It requires validated equipment, continuous monitoring, alarms, traceability, environmental safety, trained personnel, contingency planning, and clearly defined responsibilities.

The critical question is therefore not only whether an embryo was vitrified successfully, but whether the system protecting that embryo remains reliable throughout its entire storage period.

Vitrification is a rapid-cooling cryopreservation method and is now strongly recommended as the standard approach for cryopreservation of human oocytes and embryos (ASRM, 2021). Its purpose is to minimise ice-crystal formation during cooling and preserve cellular structures.

But vitrification is not the same as long-term storage.

After vitrification, the specimen enters a cryostorage system in which its continued preservation depends on stable cryogenic conditions and correct handling. The 2026 ESHRE recommendations emphasise that cryostorage tanks should be continuously monitored and equipped with appropriate alarm systems, while critical equipment should have contingency arrangements and backup capacity (ESHRE, 2026).

This distinction is important.

Vitrification preserves the specimen. Cryostorage preserves the laboratory’s achievement over time.

A cryobank therefore represents a continuation of laboratory quality rather than an administrative endpoint. The quality system must extend from the moment of vitrification through storage, inventory management, eventual warming and, where applicable, transport.

What does a scientifically reliable cryobank actually require?

A reliable cryobank is built around several interconnected layers of protection.

The first is cryogenic stability.

Storage vessels must maintain appropriate conditions, and their performance must be monitored. ESHRE recommends continuous monitoring of cryostorage tanks for parameters such as temperature and/or liquid-nitrogen level, with alarms for deviations. Tank integrity, vacuum performance and evaporation behaviour also require appropriate evaluation and preventive maintenance (ESHRE, 2026).

The second is redundancy.

A cryobank should not depend on a single point of failure. ESHRE recommends at least one backup cryostorage tank, while ASRM guidance also emphasises sufficient reserve capacity and procedures for transferring specimens when a storage vessel becomes unreliable (ESHRE, 2026; ASRM, 2020).

The third is identification and traceability.

A perfectly preserved embryo is of no clinical value if its identity, location or storage record becomes uncertain. Cryostorage therefore requires accurate labelling, inventory control and documentation of specimen identity, cryopreservation method, date, operator, developmental stage where relevant, storage device and location. Critical handling steps should include appropriate identity and specimen-number checks (ESHRE, 2026).

The fourth is environmental and occupational safety.

Liquid nitrogen creates hazards beyond the specimens themselves.

Cryogenic areas require appropriate ventilation, oxygen monitoring, and alarms because nitrogen displacement can reduce the oxygen concentration in the surrounding environment. Staff handling liquid nitrogen require appropriate training and personal protective equipment (ESHRE, 2026; ASRM, 2020).

These elements demonstrate why a cryobank should not be viewed simply as a collection of tanks.

It is a controlled biological preservation system.

What happens when cryostorage deviates from normal operation?

Cryostorage failure does not necessarily begin with a dramatic tank collapse.

It may begin with a gradual increase in evaporation, a vacuum problem, an autofill malfunction, a defective sensor, an alarm failure, a power interruption, inadequate liquid-nitrogen supply, or an inventory discrepancy. ASRM identifies several of these as potential sources of cryostorage failure and recommends monitoring, alarm systems, testing, and defined response procedures (ASRM, 2020).

This is where a quality system becomes more important than the equipment itself.

An alarm has value only if somebody receives it, understands its significance and responds according to a validated procedure. A backup tank has value only if it has sufficient capacity and is itself maintained in a suitable condition. A contingency plan has value only if staff know how and when to activate it.

The 2026 ESHRE recommendations therefore place emphasis not only on monitoring, but also on contingency arrangements, backup equipment, reserve liquid nitrogen and predefined procedures for emergencies. ASRM likewise recommends emergency planning capable of protecting cryopreserved specimens during equipment failure, power disruption and other unexpected events (ESHRE, 2026; ASRM, 2021).

An effective cryobank consequently operates on a simple principle:

The system must be capable of detecting failure before failure becomes specimen loss.

This also explains why quality management should include documented alarm testing, preventive maintenance, emergency procedures, staff training, and periodic review of cryostorage performance.

Infection-control considerations add another layer. Certain viruses, including HIV, HBV and HCV, can survive in liquid nitrogen, although the documented risk of cross-contamination in cryogenic storage is considered very low. ASRM recommends risk-reduction strategies such as separate canisters for specimens from patients with these infections (ASRM, 2023). Storage arrangements should therefore be based on laboratory risk assessment and applicable guidance rather than assuming that one configuration is universally required.

Who protects the embryo after vitrification?

The answer is not a single person.

The embryologist is directly involved in the scientific handling, identification, documentation and management of cryopreserved specimens, but reliable cryostorage is a shared quality responsibility involving laboratory leadership, quality management, engineering, facilities, occupational safety and organisational leadership.

The embryology team must know where specimens are stored, how the tanks are monitored, what constitutes an abnormal condition, who receives alarms, and what action follows. Laboratory leadership must ensure adequate staffing, validated procedures, equipment maintenance and emergency preparedness. Facilities and engineering teams contribute to environmental control, ventilation, power, and equipment support. Quality management connects these elements through documentation, auditing, corrective actions, and continual improvement.

This multidisciplinary structure is consistent with the broader laboratory-management approach described by ASRM (2022).

The deeper scientific point is that cryostorage introduces a different dimension of laboratory quality: time.

Embryo culture is measured in days. Vitrification is completed within a defined procedure. Cryostorage may extend across years. During that period, the laboratory must continue to preserve not only the biological specimen but also its identity, location, documentation, and access pathway.

Therefore, the final quality question in an IVF laboratory is not simply:

‘Did we vitrify the embryo successfully?’

It is:

‘Can we demonstrate that the embryo remained identifiable, cryogenically protected and safely retrievable throughout its storage period?’

Vitrification preserves the specimen.

Cryostorage preserves the laboratory’s achievement over time.”

Written by Saadat Hassan
Senior Clinical Embryologist/IVF and Embryology
BSc (Hons) Medical Laboratory Technology
King Edward Medical University, Lahore, Pakistan

References

Title: ESHRE recommendations on Good Practice in the IVF laboratory

Authors: ESHRE Good Practice in the IVF Lab Working Group, Gemma Arroyo, Amy Barrie, Giovanni Coticchio, Thomas Ebner, Jackson Kirkman-Brown, Nathalie Le Clef, Kersti Lundin, Cristina Magli, Marina Quesada Martinez, Maria José de los Santos Molina, Kelly Tilleman, Ioannis Sfontouris

You can read the Full Article in Human Reproduction.

Title: Cryostorage of reproductive tissues in the in vitro fertilization laboratory: a committee opinion

Authors: Practice Committees of the American Society for Reproductive Medicine, Society for Reproductive Biologists and Technologists, and Society for Assisted Reproductive Technology

You can read the Full Article in Fertility and Sterility.

Title: Comprehensive guidance for human embryology, andrology, and endocrinology laboratories: management and operations: a committee opinion

Authors: Practice Committees of the American Society for Reproductive Medicine (ASRM) and the Society for Reproductive Biologists and Technologists (SRBT)

You can read the Full Article in Fertility and Sterility.

Title: A review of best practices of rapid-cooling vitrification for oocytes and embryos: a committee opinion

Authors: Practice Committees of the American Society for Reproductive Medicine and Society of Reproductive Biologists and Technologists

You can read the Full Article in Fertility and Sterility.

Title: Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion

Authors: Practice Committee of the American Society for Reproductive Medicine

You can read the Full Article in Fertility and Sterility.

Title: Development of an emergency plan for in vitro fertilization programs: a committee opinion

Authors: Practice Committees of the American Society for Reproductive Medicine, the Society for Assisted Reproductive Technology, and the Society of Reproductive Biologists and Technologists

You can read the Full Article in Fertility and Sterility.

Other articles featuring Saadat Hassan on Fertility News.